{"id":"https://openalex.org/W1495969130","doi":"https://doi.org/10.1002/pbc.24619","title":"Alternative formulations of sorafenib for use in children","display_name":"Alternative formulations of sorafenib for use in children","publication_year":2013,"publication_date":"2013-06-20","ids":{"openalex":"https://openalex.org/W1495969130","doi":"https://doi.org/10.1002/pbc.24619","mag":"1495969130","pmid":"https://pubmed.ncbi.nlm.nih.gov/23788485","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3800690"},"language":"en","primary_location":{"id":"doi:10.1002/pbc.24619","doi":"https://doi.org/10.1002/pbc.24619","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pbc.24619","pdf_url":null,"source":{"id":"https://openalex.org/S119714264","display_name":"Pediatric Blood & Cancer","issn_l":"1545-5009","issn":["1545-5009","1545-5017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Blood & Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3800690","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045180889","display_name":"Fariba Navid","orcid":"https://orcid.org/0000-0002-7916-6382","observed_orcids":["https://orcid.org/0000-0002-7916-6382"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Fariba Navid","raw_affiliation_strings":["Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee","Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103466284","display_name":"Robbin Christensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robbin Christensen","raw_affiliation_strings":["Department of Pharmaceutical Services, St. Jude Children's Research Hospital, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Services, St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075936752","display_name":"Hiroto Inaba","orcid":"https://orcid.org/0000-0003-0605-7342","observed_orcids":["https://orcid.org/0000-0003-0605-7342"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hiroto Inaba","raw_affiliation_strings":["Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee","Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]},{"raw_affiliation_string":"Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016647580","display_name":"Lie Li","orcid":"https://orcid.org/0000-0003-1508-5484","observed_orcids":["https://orcid.org/0000-0003-1508-5484"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lie Li","raw_affiliation_strings":["Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089372630","display_name":"Zhaoyuan Chen","orcid":"https://orcid.org/0009-0004-3453-6820","observed_orcids":["https://orcid.org/0009-0004-3453-6820"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhaoyuan Chen","raw_affiliation_strings":["Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102078704","display_name":"Xiangjun Cai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiangjun Cai","raw_affiliation_strings":["Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089060005","display_name":"Joshua Regel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua Regel","raw_affiliation_strings":["Regel PharmaLab, Cordova, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regel PharmaLab, Cordova, Tennessee","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":["Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee","institution_ids":["https://openalex.org/I1313298211"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5045180889"],"corresponding_institution_ids":["https://openalex.org/I1313298211","https://openalex.org/I160606119"],"apc_list":{"value":4640,"currency":"USD","value_usd":4640},"apc_paid":null,"fwci":0.3162,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.63570829,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"60","issue":"10","first_page":"1642","last_page":"1646"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9240000247955322},{"id":"https://openalex.org/keywords/pediatric-drug-formulation","display_name":"pediatric formulations","score":0.6890000104904175},{"id":"https://openalex.org/keywords/extemporaneous-compounding","display_name":"extemporaneous compounding","score":0.8960000276565552},{"id":"https://openalex.org/keywords/oral-suspension","display_name":"oral suspension","score":0.4009999930858612},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.7039999961853027},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7919999957084656},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.8050000071525574},{"id":"https://openalex.org/keywords/pediatric-oncology","display_name":"pediatric oncology","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9734401702880859},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7777689695358276},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7470628023147583},{"id":"https://openalex.org/C2778778583","wikidata":"https://www.wikidata.org/wiki/Q147768","display_name":"Capsule","level":2,"score":0.6037376523017883},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5102357864379883},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.5088019967079163},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5002479553222656},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4747617244720459},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4576321244239807},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.42887288331985474},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17859718203544617},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10871058702468872},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.07508012652397156},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/pbc.24619","doi":"https://doi.org/10.1002/pbc.24619","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pbc.24619","pdf_url":null,"source":{"id":"https://openalex.org/S119714264","display_name":"Pediatric Blood & Cancer","issn_l":"1545-5009","issn":["1545-5009","1545-5017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Blood & Cancer","raw_type":"journal-article"},{"id":"pmid:23788485","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23788485","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric blood & cancer","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:3800690","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3800690","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Pediatr Blood Cancer","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3800690","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3800690","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Pediatr Blood Cancer","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2564957956","display_name":"Tyrosine kinase inhibitors for the treatment of childhood AML","funder_award_id":"R01CA138744","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5145123177","display_name":"Studies of Childhood Solid Tumors","funder_award_id":"P01CA023099","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000904664","display_name":"Cancer Center Support Grant (CCSG)","funder_award_id":"P30CA021765","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320313598","display_name":"American Lebanese Syrian Associated Charities","ror":"https://ror.org/03rx10x31"},{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320332487","display_name":"Onyx Pharmaceuticals","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320335359","display_name":"Pharmaceuticals Bayer","ror":null},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1971640156","https://openalex.org/W1971837077","https://openalex.org/W1982134486","https://openalex.org/W1986512306","https://openalex.org/W1997533142","https://openalex.org/W2087463734","https://openalex.org/W2108300554","https://openalex.org/W2140172669","https://openalex.org/W2144530818","https://openalex.org/W2151507583","https://openalex.org/W2157262448","https://openalex.org/W2158927044","https://openalex.org/W2167348613","https://openalex.org/W2242959230"],"related_works":["https://openalex.org/W1982134486","https://openalex.org/W2242959230","https://openalex.org/W1988484139","https://openalex.org/W2248974608","https://openalex.org/W2782819754","https://openalex.org/W1566978183","https://openalex.org/W3164436955","https://openalex.org/W2900123548","https://openalex.org/W3189643800","https://openalex.org/W2117363365"],"abstract_inverted_index":{"BACKGROUND:":[0],"Sorafenib":[1,176,200],"is":[2,21,201],"an":[3,205],"oral":[4,206],"multikinase":[5],"inhibitor":[6],"with":[7,105,188],"antiangiogenic":[8],"and":[9,32,39,47,73,76,83,97,114,165,194],"antitumor":[10],"activity.":[11],"In":[12,139,148],"most":[13],"cases,":[14],"the":[15,30,41,133,154,162],"commercially":[16,210],"available":[17,56,211],"200":[18,57],"mg":[19,58,85,156],"tablet":[20],"not":[22,202],"suitable":[23],"for":[24,171,230],"administration":[25,231],"to":[26,65,77,130,232],"children.":[27,53],"We":[28],"studied":[29],"chemical":[31],"physical":[33],"stability":[34],"of":[35,44,50,60,69,89,132,136,161],"extemporaneously":[36],"prepared":[37,208],"formulations":[38],"evaluated":[40],"pharmacokinetic":[42,177],"profile":[43],"cut":[45,98,184,226],"tablets":[46,59,185,227],"smaller-dosage":[48,151,217],"capsules":[49,96,182,215],"sorafenib":[51,61,70,90,117,142],"in":[52,71,93,119,179,192,204,216],"PROCEDURE:":[54],"Commercially":[55],"tosylate":[62],"were":[63,91,123,144,158,166,186],"used":[64],"prepare":[66,78],"liquid":[67],"suspensions":[68],"oil":[72,140],"Ora-Plus(\u00ae):Ora-Sweet(\u00ae)":[74],"solution,":[75],"5,":[79],"10,":[80],"20,":[81],"50,":[82],"100":[84],"capsules.":[86],"Plasma":[87],"concentrations":[88,118,143],"measured":[92],"patients":[94,180],"receiving":[95,181,196],"tablets,":[99,212],"using":[100],"a":[101],"validated":[102],"HPLC-based":[103],"method":[104],"tandem":[106],"mass":[107],"spectrometric":[108],"detection.":[109],"RESULTS:":[110],"At":[111],"room":[112,169],"temperature":[113,170],"under":[115],"refrigeration,":[116],"Ora":[120],"Plus(\u00ae):Ora":[121],"Sweet(\u00ae)":[122],"highly":[124],"variable":[125],"(means":[126],"ranging":[127],"from":[128,209],"75%":[129],"131%":[131],"intended":[134,163],"concentration":[135],"50":[137],"mg/ml).":[138],"suspension,":[141],"inconsistent":[145],"during":[146],"compounding.":[147],"contrast,":[149],"all":[150],"capsules,":[152],"except":[153],"5":[155],"capsule,":[157],"within":[159],"91-99%":[160],"content":[164],"stable":[167,203],"at":[168,172],"least":[173],"8":[174],"months.":[175],"parameters":[178],"or":[183,225,243],"consistent":[187],"those":[189],"reported":[190],"previously":[191],"adults":[193],"children":[195,233],"intact":[197],"tablets.":[198,246],"CONCLUSIONS:":[199],"suspension":[207],"but":[213],"compounded":[214],"forms":[218],"that":[219],"can":[220],"be":[221],"sprinkled":[222],"on":[223,239],"food":[224],"are":[228],"alternatives":[229],"who":[234],"need":[235],"smaller":[236],"doses":[237],"based":[238],"body":[240],"surface":[241],"area":[242],"cannot":[244],"swallow":[245]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}